TheraCryf (FRA:8EV) Other Long Term Assets : €-0.00 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Other Long Term Assets?

TheraCryf's other long-term assets for the quarter that ended in Sep. 2023 was €-0.00 Mil.

TheraCryf's quarterly other long-term assets declined from Sep. 2022 (€0.00 Mil) to Mar. 2023 (€0.00 Mil) but then stayed the same from Mar. 2023 (€0.00 Mil) to Sep. 2023 (€-0.00 Mil).

TheraCryf's annual other long-term assets declined from Mar. 2021 (€0.00 Mil) to Mar. 2022 (€-0.00 Mil) but then increased from Mar. 2022 (€-0.00 Mil) to Mar. 2023 (€0.00 Mil).

TheraCryf Other Long Term Assets Historical Data

The historical data trend for TheraCryf's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Other Long Term Assets Chart

TheraCryf Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long Term Assets

Get a 7-Day Free Trial

TheraCryf Semi-Annual Data
	Mar13	Mar14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

TheraCryf Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

TheraCryf (FRA:8EV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

EVG:UK

Address

Congleton Road, Suite 24G13- Block 24, Alderley Park, Nether Alderley, GBR, SK10 4TG

Website

https://www.evgen.com

Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.

TheraCryf (FRA:8EV) Headlines

No Headlines